Cover Image
市場調查報告書

抗體產生的全球市場預測 2021年:上游流程、下游流程、過濾

Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes) - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 329404
出版日期 內容資訊 英文 213 Pages
訂單完成後即時交付
價格
Back to Top
抗體產生的全球市場預測 2021年:上游流程、下游流程、過濾 Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes) - Global Forecast to 2021
出版日期: 2016年08月18日 內容資訊: 英文 213 Pages
簡介

抗體產生市場規模預計從2016年到2021年以12.3%的年複合成長率發展,從2016年的74億5,000萬美元到2021年達到132億8,000萬美元。

本報告提供全球抗體產生市場相關調查,各流程、終端用戶及各地區的分析與預測,及參與企業簡介等彙整資料。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 重要考察

  • 抗體產生:市場概要
  • 抗體產生市場規模:各流程
  • 抗體產生市場規模:各終端用戶

第5章 抗體產生的全球市場:概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 課題

第6章 抗體產生的全球市場:各流程

  • 簡介
  • 上游流程
    • 生物反應器
    • 消耗品
  • 下游流程
    • 層析法計量儀器
    • 層析法樹脂
  • 離子交換 (IEX) 層析法樹脂
  • 疏水交互作用層析法 (HIC) 樹脂
  • 多模態層析法樹脂
  • 過濾
    • 過濾系統
    • 過濾消耗品、配件

第7章 抗體產生的全球市場:各終端用戶

  • 簡介
    • 醫藥品、生物科技企業
    • 診斷實驗室
    • 研究機關

第8章 抗體產生的全球市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他的歐洲 (ROE)
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他的亞太地區
  • 其他
    • 南美
    • 中東非洲 (MEA)

第9章 競爭情形

  • 概要
  • 策略概要
  • 競爭情形、趨勢

第10章 企業簡介

  • 簡介
  • GE HEALTHCARE (GENERAL ELECTRIC COMPANY 子公司)
  • MERCK KGAA
  • THERMO FISHER SCIENTIFIC, INC.
  • SARTORIUS AG
  • PALL CORPORATION (DANAHER CORPORATION 的收購)
  • SIGMA-ALDRICH CORPORATION (MERCK KGAA 的收購)
  • EPPENDORF AG
  • CELLAB GMBH
  • INTEGRA BIOSCIENCES AG
  • FIBERCELL SYSTEMS INC.

第11章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 3363

The antibody production market is projected to reach USD 13.28 billion by 2021 from USD 7.45 billion in 2016, at a CAGR of 12.3% during the forecast period of 2016 to 2021. The antibody production market comprises products required during the different stages of bioprocessing of antibodies, such as upstream processing, downstream processing, and filtration.

The consumables segment is expected to account for the largest share of the antibody production products market, by upstream processing. Media and reagents are the major consumables involved in the upstream processing of antibodies. Media contain compounds that help in regulating the cell cycle. Reagents and buffers aid in maintaining an optimal pH level. The mandatory requirement of changing consumable sets for every batch results in their repeat purchase, thereby driving the growth of this market segment. Among the end users in the market, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the antibody production market, and register the highest CAGR during the forecast period. Pharmaceutical and biotechnology companies use antibody production equipment and consumables to produce therapeutic antibodies as well as to carry out R&D for developing novel immunotherapies.

North America is expected to account for the largest share of the antibody production market in 2016, followed by Europe. The large share of the North America region can be attributed to the rising cancer incidence, government funding for medical research in the U.S., need for quality cancer treatment, and growth in the number of regulatory approvals and authorization for use of mAbs in Canada. Asia-Pacific is expected to witness the highest growth rate in the forecast period, mainly due to increasing government and private-sector investments in China's life sciences market, increasing government initiatives and growing pharmaceutical industry in India, and infrastructural development along with government support for strong academic and commercial R&D in the rest of Asia-Pacific.

The antibody production market witnesses high competitive intensity as there are several large and many small firms with similar product offerings. These companies adopt various strategies (new product launches, agreements, partnerships, collaborations acquisitions, and expansions) to increase their market shares and establish a strong foothold in the global market.

The prominent players in the antibody production market include GE Healthcare (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Pall Corporation (U.S.), Sigma-Aldrich Corporation (Germany), Eppendorf AG (Germany), Cellab GmbH (Germany), INTEGRA Biosciences AG (Switzerland), and FiberCell Systems Inc. (U.S.).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the antibody production market. The report analyzes the market based on process, and end user
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the antibody production market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various antibody production across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the antibody production market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the antibody production market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key industry insights
      • 2.2.2.2. Key data from primary sources
      • 2.2.2.3. Key Insights from primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET FORECAST METHODOLOGY
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT AND FUTURE SCENARIO
  • 3.3. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. ANTIBODY PRODUCTION: MARKET OVERVIEW
  • 4.2. ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2016 VS. 2021
  • 4.3. ANTIBODY PRODUCTION MARKET SIZE, BY END USER, 2016 VS. 2021

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. U.S. FDA clearance of therapeutic mAbs
      • 5.3.1.2. Increasing adoption of targeted immunotherapy
      • 5.3.1.3. Increasing R&D expenditure in pharmaceutical and biotechnological companies
      • 5.3.1.4. Rising number of Fast Track and Orphan Drug designations
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Cost constraints related to the adoption of membrane filters
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Rising demand for protein therapeutics
      • 5.3.3.2. Increasing risk of infectious diseases
      • 5.3.3.3. Patent expiry of blockbuster mAbs
    • 5.3.4. CHALLENGES
      • 5.3.4.1. High costs of primary antibodies

6. ANTIBODY PRODUCTION MARKET, BY PROCESS

  • 6.1. INTRODUCTION
  • 6.2. UPSTREAM PROCESSING
    • 6.2.1. BIOREACTORS
      • 6.2.1.1. Large-scale bioreactors
      • 6.2.1.2. Single-use bioreactors (SUBs)
    • 6.2.2. CONSUMABLES
      • 6.2.2.1. Media
      • 6.2.2.2. Reagents and buffers
  • 6.3. DOWNSTREAM PROCESSING
    • 6.3.1. CHROMATOGRAPHY INSTRUMENTS
    • 6.3.2. CHROMATOGRAPHY RESINS
      • 6.3.2.1. Affinity Chromatography Resins
  • 6.4. ION EXCHANGE (IEX) CHROMATOGRAPHY RESINS
  • 6.5. HYDROPHOBIC INTERACTION CHROMATOGRAPHY (HIC) RESINS
  • 6.6. MULTIMODAL CHROMATOGRAPHY RESINS
  • 6.7. FILTRATION
    • 6.7.1. FILTRATION SYSTEMS
    • 6.7.2. FILTRATION CONSUMABLES AND ACCESSORIES

7. ANTIBODY PRODUCTION MARKET, BY END USER

  • 7.1. INTRODUCTION
    • 7.1.1. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 7.1.2. DIAGNOSTIC LABORATORIES
    • 7.1.3. RESEARCH INSTITUTES

8. GLOBAL ANTIBODY PRODUCTION MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. U.S.
      • 8.2.1.1. Rising cancer incidence in the U.S.
      • 8.2.1.2. Government funding for medical research
      • 8.2.1.3. Conferences, symposia, and seminars on bioprocessing technologies
    • 8.2.2. CANADA
      • 8.2.2.1. Government initiatives to promote research
      • 8.2.2.2. Need for quality cancer treatment
      • 8.2.2.3. Regulatory approvals and authorization for use of mAbs
  • 8.3. EUROPE
    • 8.3.1. GERMANY
      • 8.3.1.1. Increasing focus on R&D
      • 8.3.1.2. Government funding
    • 8.3.2. U.K.
      • 8.3.2.1. Flourishing biotechnology and biopharmaceutical industry
    • 8.3.3. FRANCE
      • 8.3.3.1. Growing presence of chromatography players in France
    • 8.3.4. REST OF EUROPE (ROE)
      • 8.3.4.1. Investments and funding for life sciences to bolster the antibody production market
  • 8.4. ASIA-PACIFIC
    • 8.4.1. JAPAN
      • 8.4.1.1. Growing biopharmaceutical sector and rise in geriatric population
    • 8.4.2. CHINA
      • 8.4.2.1. Increasing government and private-sector investments in China's life sciences market
      • 8.4.2.2. Outsourcing of clinical research activities to China
    • 8.4.3. INDIA
      • 8.4.3.1. Increasing government initiatives and growing pharmaceutical industry in India
      • 8.4.3.2. Development of bioclusters to boost India's biotechnology industry
    • 8.4.4. REST OF ASIA-PACIFIC
      • 8.4.4.1. Funding from the Australian government for scientific research and innovation
      • 8.4.4.2. Infrastructural development in Vietnam
      • 8.4.4.3. Rising pharmaceutical and biotechnology R&D activities in Korea
      • 8.4.4.4. Government support for strong academic and commercial R&D activities in Taiwan
  • 8.5. REST OF THE WORLD
    • 8.5.1. LATIN AMERICA
      • 8.5.1.1. Pharmaceutical, biotechnology, and research industries in Brazil to bolster the market
      • 8.5.1.2. Mexico, the production hub for global pharmaceutical companies
    • 8.5.2. MIDDLE EAST AND AFRICA (MEA)
      • 8.5.2.1. Favorable business environment for pharmaceutical and biotechnology industries in Saudi Arabia and UAE
      • 8.5.2.2. Increasing focus on Africa by pharmaceutical companies

9. COMPETITIVE LANDSCAPE

  • 9.1. OVERVIEW
  • 9.2. STRATEGIC OVERVIEW
  • 9.3. COMPETITIVE SITUATION AND TRENDS
    • 9.3.1. NEW PRODUCT LAUNCHES
    • 9.3.2. EXPANSIONS
    • 9.3.3. AGREEMENTS, ALLIANCES, PARTNERSHIPS, AND COLLABORATIONS
    • 9.3.4. MERGERS AND ACQUISITIONS
    • 9.3.5. OTHER STRATEGIES

10. COMPANY PROFILES (Company at a Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MNM View)*

  • 10.1. INTRODUCTION
  • 10.2. GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
  • 10.3. MERCK KGAA
  • 10.4. THERMO FISHER SCIENTIFIC, INC.
  • 10.5. SARTORIUS AG
  • 10.6. PALL CORPORATION (ACQUIRED BY DANAHER CORPORATION)
  • 10.7. SIGMA-ALDRICH CORPORATION (ACQUIRED BY MERCK KGAA)
  • 10.8. EPPENDORF AG
  • 10.9. CELLAB GMBH
  • 10.10. INTEGRA BIOSCIENCES AG
  • 10.11. FIBERCELL SYSTEMS INC.

*Details on company at a glance, recent financials, Products offered, strategies & insights, & recent developments might not be captured in case of unlisted companies.

11. APPENDIX

  • 11.1. INSIGHTS OF INDUSTRY EXPERTS
  • 11.2. DISCUSSION GUIDE
  • 11.3. OTHER DEVELOPMENTS (2013-2016)
    • 11.3.1. GE HEALTHCARE
    • 11.3.2. MERCK KGAA
    • 11.3.3. THERMO FISHER SCIENTIFIC, INC.
    • 11.3.4. SARTORIUS AG
    • 11.3.5. SIGMA-ALDRICH CORPORATION (ACQUIRED BY MERCK KGAA)
    • 11.3.6. EPPENDORF AG
    • 11.3.7. INTEGRA BIOSCIENCES GROUP
  • 11.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 11.6. AVAILABLE CUSTOMIZATIONS
  • 11.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INCREASING LIFE SCIENCE R&D EXPENDITURE IS PROPELLING THE GROWTH OF THE ANTIBODY PRODUCTION MARKET
  • TABLE 2: COST CONSTRAINTS RELATED TO THE ADOPTION OF MEMBRANE FILTERS TO RESTRAIN THE MARKET
  • TABLE 3: PATENT EXPIRY OF BLOCKBUSTER MABS OFFERS HUGE POTENTIAL FOR THE ANTIBODY PRODUCTION MARKET
  • TABLE 4: HIGH COSTS OF PRIMARY ANTIBODIES POSING AS A CHALLENGE FOR THE GROWTH OF THE ANTIBODY PRODUCTION MARKET
  • TABLE 5: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 6: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 7: UPSTREAM PROCESSING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: NORTH AMERICA: UPSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: EUROPE: UPSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 10: ASIA-PACIFIC: UPSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: ROW: UPSTREAM PROCESSING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 13: BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: NORTH AMERICA: BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: EUROPE: BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: ASIA-PACIFIC: BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: ROW: BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: LARGE-SCALE BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: NORTH AMERICA: LARGE-SCALE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: EUROPE: LARGE-SCALE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: ASIA-PACIFIC: LARGE-SCALE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: ROW: LARGE-SCALE BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: SINGLE-USE BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: ASIA-PACIFIC: SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 27: ROW: SINGLE-USE BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 29: CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: NORTH AMERICA: CONSUMABLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: EUROPE: CONSUMABLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: ASIA-PACIFIC: CONSUMABLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: ROW: CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: MEDIA MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: NORTH AMERICA: MEDIA MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 36: EUROPE: MEDIA MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: ASIA-PACIFIC: MEDIA MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: ROW: MEDIA MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: REAGENTS AND BUFFERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: REAGENTS AND BUFFERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: EUROPE: REAGENTS AND BUFFERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: ASIA-PACIFIC: REAGENTS AND BUFFERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: ROW: REAGENTS AND BUFFERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 44: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 45: DOWNSTREAM PROCESSING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: DOWNSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE: DOWNSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: ASIA-PACIFIC: DOWNSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: ROW: DOWNSTREAM PROCESSING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 50: CHROMATOGRAPHY INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 51: NORTH AMERICA: CHROMATOGRAPHY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: EUROPE: CHROMATOGRAPHY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: ASIA-PACIFIC: CHROMATOGRAPHY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 54: ROW: CHROMATOGRAPHY INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 55: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 56: CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 57: NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 59: ASIA-PACIFIC: CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 60: ROW: CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 61: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 62: NORTH AMERICA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 63: EUROPE: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 64: ASIA-PACIFIC: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 65: ROW: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 66: IEX CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 67: NORTH AMERICA: IEX CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 68: EUROPE: IEX CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 69: ASIA-PACIFIC: IEX CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 70: ROW: IEX CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 71: HIC CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 72: NORTH AMERICA: HIC RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 73: EUROPE: HIC RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 74: ASIA-PACIFIC: HIC RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 75: ROW: HIC RESINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 76: MULTIMODAL CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 77: NORTH AMERICA: MULTIMODAL CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 78: EUROPE: MULTIMODAL CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 79: ASIA-PACIFIC: MULTIMODAL CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 80: ROW: MULTIMODAL CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 81: FILTRATION MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 82: FILTRATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 83: NORTH AMERICA: FILTRATION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 84: EUROPE: FILTRATION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 85: ASIA-PACIFIC: FILTRATION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 86: ROW: FILTRATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 87: FILTRATION SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 88: NORTH AMERICA: FILTRATION SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 89: EUROPE: FILTRATION SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 90: ASIA-PACIFIC: FILTRATION SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 91: ROW: FILTRATION SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 92: FILTRATION CONSUMABLES AND ACCESSORIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 93: NORTH AMERICA: FILTRATION CONSUMABLES AND ACCESSORIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 94: EUROPE: FILTRATION CONSUMABLES AND ACCESSORIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 95: ASIA-PACIFIC: FILTRATION CONSUMABLES AND ACCESSORIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 96: ROW: FILTRATION CONSUMABLES AND ACCESSORIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 97: ANTIBODY PRODUCTION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 98: ANTIBODY PRODUCTION MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 99: ANTIBODY PRODUCTION MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 100: ANTIBODY PRODUCTION MARKET SIZE FOR RESEARCH INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 101: ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 102: NORTH AMERICA: ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 103: NORTH AMERICA: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 104: NORTH AMERICA: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 105: NORTH AMERICA: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 106: NORTH AMERICA: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 107: NORTH AMERICA: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 108: NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 109: NORTH AMERICA: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 110: U.S.: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 111: U.S.: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 112: U.S.: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 113: U.S.: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 114: U.S.: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 115: U.S.: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 116: U.S.: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 117: CANADA: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 118: CANADA: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 119: CANADA: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 120: CANADA: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 121: CANADA: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 122: CANADA: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 123: CANADA: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 124: EUROPE: ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 125: EUROPE: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 126: EUROPE: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 127: EUROPE: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 128: EUROPE: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 129: EUROPE: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 130: EUROPE: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 131: EUROPE: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 132: GERMANY: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 133: GERMANY: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 134: GERMANY: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 135: GERMANY: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 136: GERMANY: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 137: GERMANY: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 138: GERMANY: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 139: U.K.: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 140: U.K.: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 141: U.K.: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 142: U.K.: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 143: U.K.: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 144: U.K.: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 145: U.K.: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 146: FRANCE: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 147: FRANCE: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 148: FRANCE: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 149: FRANCE: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 150: FRANCE: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 151: FRANCE: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 152: FRANCE: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 153: ROE: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 154: ROE: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 155: ROE: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 156: ROE: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 157: ROE: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 158: ROE: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 159: ROE: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 160: ASIA-PACIFIC: ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 161: ASIA-PACIFIC: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 162: ASIA-PACIFIC: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 163: ASIA-PACIFIC: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 164: ASIA-PACIFIC: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 165: ASIA-PACIFIC: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 166: ASIA-PACIFIC: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 167: ASIA-PACIFIC: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 168: JAPAN: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 169: JAPAN: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 170: JAPAN: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 171: JAPAN: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 172: JAPAN: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 173: JAPAN: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 174: JAPAN: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 175: CHINA: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 176: CHINA: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 177: CHINA: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 178: CHINA: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 179: CHINA: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 180: CHINA: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 181: CHINA: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 182: INDIA: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 183: INDIA: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 184: INDIA: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 185: INDIA: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 186: INDIA: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 187: INDIA: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 188: INDIA: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 189: ROAPAC: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 190: ROAPAC: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 191: ROAPAC: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 192: ROAPAC: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 193: ROAPAC: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 194: ROAPAC: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 195: ROAPAC: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 196: ROW: ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 197: ROW: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 198: ROW: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 199: ROW: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 200: ROW: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 201: ROW: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 202: ROW: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 203: ROW: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 204: LATIN AMERICA: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 205: LATIN AMERICA: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 206: LATIN AMERICA: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 207: LATIN AMERICA: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 208: LATIN AMERICA: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 209: LATIN AMERICA: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 210: LATIN AMERICA: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 211: MEA: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014-2021 (USD MILLION)
  • TABLE 212: MEA: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 213: MEA: BIOREACTORS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 214: MEA: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 215: MEA: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 216: MEA: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 217: MEA: FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 218: NEW PRODUCT LAUNCHES (2013-2016)
  • TABLE 219: EXPANSIONS (2013-2016)
  • TABLE 220: AGREEMENTS, ALLIANCES, PARTNERSHIPS, AND COLLABORATIONS (2013-2016)
  • TABLE 222: OTHER STRATEGIES (2013-2016)

LIST OF FIGURES

  • FIGURE 1: GLOBAL ANTIBODY PRODUCTION MARKET SEGMENTATION
  • FIGURE 2: GLOBAL ANTIBODY PRODUCTION MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS (2016 VS. 2021)
  • FIGURE 9: GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY END USER, 2016 VS. 2021
  • FIGURE 10: ASIA-PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 11: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE ANTIBODY PRODUCTION MARKET IN 2016
  • FIGURE 12: DOWNSTREAM PROCESSING SEGMENT TO WITNESS THE HIGHEST GROWTH RATE FROM 2016 TO 2021
  • FIGURE 13: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2021
  • FIGURE 14: ANTIBODY PRODUCTION MARKET SEGMENTATION
  • FIGURE 15: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 16: APPROVALS OF THERAPEUTIC MONOCLONAL ANTIBODIES IN THE U.S. (1995-2015)
  • FIGURE 17: DOWNSTREAM PROCESSING TO COMMAND THE LARGEST SHARE OF THE ANTIBODY PRODUCTION MARKET, BY PROCESS
  • FIGURE 18: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES END-USER SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 19: ANTIBODY PRODUCTION MARKET, BY REGION, 2016
  • FIGURE 20: NORTH AMERICA: ANTIBODY PRODUCTION MARKET SNAPSHOT
  • FIGURE 21: EUROPE: ANTIBODY PRODUCTION MARKET SNAPSHOT
  • FIGURE 22: ASIA-PACIFIC: ANTIBODY PRODUCTION MARKET SNAPSHOT
  • FIGURE 23: ROW: ANTIBODY PRODUCTION MARKET SNAPSHOT
  • FIGURE 24: LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY FROM 2013 TO 2016
  • FIGURE 25: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS (2013-2016)
  • FIGURE 26: NEW PRODUCT LAUNCHES, BY COMPANY (2013-2016)
  • FIGURE 27: EXPANSIONS, BY COMPANY (2013-2016)
  • FIGURE 28: AGREEMENTS, ALLIANCES, PARTNERSHIPS, AND COLLABORATIONS (2013-2016)
  • FIGURE 29: MERGER AND ACQUISITIONS, BY COMPANY (2013-2016)
  • FIGURE 30: OTHER STRATEGIES, BY COMPANY (2013-2016)
  • FIGURE 31: GEOGRAPHIC REVENUE MIX OF THE PROMINENT PLAYERS (2015)
  • FIGURE 32: GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 33: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 34: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 35: SARTORIUS AG: COMPANY SNAPSHOT
  • FIGURE 36: PALL CORPORATION: COMPANY SNAPSHOT
  • FIGURE 37: SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
  • FIGURE 38: EPPENDORF AG: COMPANY SNAPSHOT
Back to Top